Jung-Mi Hah

7PUBLICATIONS
7CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesProteomics and intermolecular interactions (excl. medical proteomics)EnzymesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 14, 2026
Protein kinases as therapeutic targets in Alzheimer's disease: challenges, insights, and new frontiers.

|Jul 13, 2026
Selective JNK3 Inhibition Ameliorates TGF-β-Mediated Glomerular Injury and Fibrosis in the Kidneys.

|Jan 23, 2026
c-Jun N-Terminal Kinase 3 as a Pathogenic Driver of Renal Fibrosis: Imidazo[2,1-b]thiazole-Based JNK3 Inhibitors Restore Podocyte Function in TGF-β-Mediated Glomerulosclerosis.

Joonhong Jun, Suyeon Choi, Jihyun Moon

|Sep 08, 2025
Advances in JNK inhibitor development: therapeutic prospects in neurodegenerative diseases and fibrosis.

Swapnil P Bhujbal, Jung-Mi Hah

|May 11, 2024
Gaining Insights into Key Structural Hotspots within the Allosteric Binding Pockets of Protein Kinases.

Swapnil P Bhujbal, Joonhong Jun, Haebeen Park

|Mar 26, 2024
Targeting the CSF-1/CSF-1R Axis: Exploring the Potential of CSF1R Inhibitors in Neurodegenerative Diseases.

Jihyun Baek, Joonhong Jun, Hyejin Kim

Pageof 2

Frequent Collaborators

1 joint publications

Soo-Jin Kim

1 joint publications

Soo Kyung Lee

1 joint publications

Ranjan Das

1 joint publications

Swapnil P Bhujbal